SCHRODER INVESTMENT MANAGEMENT GROUP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 294 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$26,000
-72.3%
589
-64.5%
0.00%
Q4 2020$94,000
+118.6%
1,658
+75.1%
0.00%
Q3 2020$43,000
-42.7%
947
-25.6%
0.00%
Q2 2020$75,000
+5.6%
1,272
-8.6%
0.00%
Q1 2020$71,000
-93.6%
1,392
-92.5%
0.00%
-100.0%
Q3 2019$1,101,000
+18.4%
18,647
+62.7%
0.00%0.0%
Q1 2019$930,000
+43.5%
11,460
-4.4%
0.00%
+100.0%
Q4 2018$648,000
-10.7%
11,984
-14.9%
0.00%0.0%
Q3 2018$726,000
+172.9%
14,080
+179.0%
0.00%
Q3 2017$266,000
-33.7%
5,047
-34.9%
0.00%
-100.0%
Q2 2017$401,0007,7490.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders